Recombinant Human IFNA1/Interferon alpha-D Protein, GST

Introduction to Recombinant Human IFNA1/Interferon alpha-D Protein

Recombinant Human IFNA1/Interferon alpha-D Protein is a type I interferon that plays a crucial role in the body’s immune response against viral infections and cancer. It is a recombinant protein, meaning it is produced through genetic engineering techniques, and is identical to the naturally occurring human IFNA1 protein. This protein has a complex structure and exhibits a wide range of activities, making it a valuable tool in both research and therapeutic applications.

Structure of Recombinant Human IFNA1/Interferon alpha-D Protein

The structure of Recombinant Human IFNA1/Interferon alpha-D Protein is composed of a single chain of 166 amino acids, with a molecular weight of approximately 19 kDa. It is a glycoprotein, meaning it contains sugar molecules attached to the protein backbone. The protein has a three-dimensional structure, with four alpha-helices and a long loop region that is essential for its biological activity.

Activity of Recombinant Human IFNA1/Interferon alpha-D Protein

Recombinant Human IFNA1/Interferon alpha-D Protein is a potent cytokine that plays a crucial role in the body’s immune response against viral infections and cancer. It acts as a signaling molecule, binding to specific receptors on the surface of cells and triggering a cascade of events that leads to the activation of the immune system. This protein has both antiviral and antitumor properties, making it a valuable tool in the treatment of various diseases.

One of the main activities of Recombinant Human IFNA1/Interferon alpha-D Protein is its ability to inhibit viral replication. It does so by inducing the expression of antiviral proteins in infected cells, which disrupt the viral life cycle and prevent the virus from spreading. This activity is particularly important in the early stages of viral infections, as it helps the body to contain and eliminate the virus before it can cause significant damage.

In addition to its antiviral activity, Recombinant Human IFNA1/Interferon alpha-D Protein also has potent antitumor effects. It can inhibit the growth and proliferation of cancer cells by inducing cell death, preventing new blood vessel formation, and enhancing the body’s immune response against cancer cells. This makes it a promising candidate for cancer treatment, either alone or in combination with other therapies.

Application of Recombinant Human IFNA1/Interferon alpha-D Protein

Due to its diverse activities, Recombinant Human IFNA1/Interferon alpha-D Protein has a wide range of applications in both research and therapeutic settings. In research, this protein is used to study the mechanisms of viral infections and cancer, as well as to develop new treatments for these diseases. It is also used to study the role of interferons in the immune system and their potential use as immunotherapies.

In therapeutic applications, Recombinant Human IFNA1/Interferon alpha-D Protein is used as a treatment for various viral infections, including hepatitis B and C, human papillomavirus (HPV), and herpes simplex virus (HSV). It is also used in the treatment of certain types of cancer, such as melanoma, leukemia, and lymphoma. This protein is administered through injection, either subcutaneously or intramuscularly, and is typically given in a series of doses over a period of time.

Conclusion

Recombinant Human IFNA1/Interferon alpha-D Protein is a powerful cytokine with diverse activities that make it a valuable tool in both research and therapeutic applications. Its complex structure and potent antiviral and antitumor properties make it a promising candidate for the treatment of various diseases. As research on this protein continues, it is expected to play an increasingly important role in the development of new treatments for viral infections and cancer.